The c-Jun NH2-Terminal Kinase 2 Plays a Dominant Role in Human Epidermal Neoplasia
- 14 April 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (8), 3080-3088
- https://doi.org/10.1158/0008-5472.can-09-2923
Abstract
The c-Jun NH2-terminal kinase (JNK) signaling cascade has been implicated in a wide range of diseases, including cancer. It is unclear how different JNK proteins contribute to human cancer. Here, we report that JNK2 is activated in more than 70% of human squamous cell carcinoma (SCC) samples and that inhibition of JNK2 pharmacologically or genetically impairs tumorigenesis of human SCC cells. Most importantly, JNK2, but not JNK1, is sufficient to couple with oncogenic Ras to transform primary human epidermal cells into malignancy with features of SCC. JNK2 prevents Ras-induced cell senescence and growth arrest by reducing the expression levels of the cell cycle inhibitor p16 and the activation of NF-κB. On the other hand, JNK, along with phosphoinositide 3-kinase, is essential for Ras-induced glycolysis, an energy-producing process known to benefit cancer growth. These data indicate that JNK2 collaborates with other oncogenes, such as Ras, at multiple molecular levels to promote tumorigenesis and hence represents a promising therapeutic target for cancer. Cancer Res; 70(8); 3080–8. ©2010 AACR.Other Versions
This publication has 46 references indexed in Scilit:
- Phosphorylation of Bad at Thr-201 by JNK1 Promotes Glycolysis through Activation of Phosphofructokinase-1Online Journal of Public Health Informatics, 2008
- MAPKs and their relevance to arthritis and inflammationRheumatology, 2007
- Suppression of p53-dependent senescence by the JNK signal transduction pathwayProceedings of the National Academy of Sciences of the United States of America, 2007
- Tumor Necrosis Factor Receptor 1/c-Jun-NH2-Kinase Signaling Promotes Human NeoplasiaCancer Research, 2007
- The tumor suppressor p16INK4a prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activityNature Structural & Molecular Biology, 2005
- JNK2: A Negative Regulator of Cellular ProliferationCell Cycle, 2004
- c-Jun N-Terminal Protein Kinase 1 (JNK1), but Not JNK2, Is Essential for Tumor Necrosis Factor Alpha-Induced c-Jun Kinase Activation and ApoptosisMolecular and Cellular Biology, 2004
- NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasiaNature, 2003
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4aCell, 1997